RETRACTED ARTICLE: Pyran Derivatives: Anti-Breast Cancer Activity and Docking Study
作者:H. Han、Z.-F. Zhang、J.-F. Zhang、B. Zhang
DOI:10.1134/s1070363218120307
日期:2018.12
Four novel pyran derivatives 1–4 are synthesized and characterized by IR, 1H NMR, HRMS, and single crystal X-ray data. Anticancer activity of the compounds is tested against four human breast cancer cells (HCC1937, HCC70, MDA-MB-436, and BT474) by MTT assay. Molecular docking study supports the biological assay data and suggests that compound 2 has a potential as an anticancer agent.
合成了四种新颖的吡喃衍生物1-4,并通过IR,1 H NMR,HRMS和单晶X射线数据对其进行了表征。通过MTT测定法测试了该化合物对四种人类乳腺癌细胞(HCC1937,HCC70,MDA-MB-436和BT474)的抗癌活性。分子对接研究支持生物学测定数据,并表明化合物2具有作为抗癌药的潜力。
SHARANINA, L. G.;NESTEROV, V. N.;KLOKOL, G. V.;RODINOVSKAYA, L. A.;SHKLOV+, ZH. ORGAN. XIMII, 1986, 22, N 6, 1315-1322
作者:SHARANINA, L. G.、NESTEROV, V. N.、KLOKOL, G. V.、RODINOVSKAYA, L. A.、SHKLOV+